ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

SCLP Scancell Holdings Plc

14.25
-0.25 (-1.72%)
26 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Scancell Holdings Plc LSE:SCLP London Ordinary Share GB00B63D3314 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.25 -1.72% 14.25 14.00 14.50 14.25 14.00 14.00 1,152,228 11:56:50
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 5.27M -11.94M -0.0129 -11.05 134.53M
Scancell Holdings Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker SCLP. The last closing price for Scancell was 14.50p. Over the last year, Scancell shares have traded in a share price range of 7.65p to 18.125p.

Scancell currently has 927,819,977 shares in issue. The market capitalisation of Scancell is £134.53 million. Scancell has a price to earnings ratio (PE ratio) of -11.05.

Scancell Share Discussion Threads

Showing 67426 to 67443 of 68025 messages
Chat Pages: Latest  2709  2708  2707  2706  2705  2704  2703  2702  2701  2700  2699  2698  Older
DateSubjectAuthorDiscuss
14/6/2024
12:23
Connello,

A stock price is controlled by traders, not investors.
Investors have already acted.
Traders are not interested in videos or potential. Many are not even aware of what the company actually do or make.
Traders are only interested in trying to profit or mitigate loss. That's it.
They buy and sell according to what the 'herd' are doing. It's irrational and emotional fear and greed. But this behaviour is patterned and therefore 'predictable'.
The mistake most PI's make is thinking like yourself.

2tyke
14/6/2024
10:02
Sci

You don’t get it and simply don’t understand reporting requirements.

Your post went on about last update was Nov and this below.

Also the CEO hinted about multiple complete responses when in fact data from additional patients would have to be RNSd


NO

They have reiterated details of the 85% including March this year in an RNS. IF it was not on track as previously reported obligations would start to kick in.

Regarding stating they must RNS new data, no not correct. They have said 70% target, current 85% response rate, 90% chance of hitting 70%.

If that hasn’t changed they don’t need to say, still on target, via regulatory news.

They have released a number of news items as regulatory which have not been price sensitive but they continue to release them as such.

The nomad decides what is and isn’t sensitive, not random CFD chasing private investors.

It seems to me they are simply holding out for the 70% target to be exceeded, then I wonder if they will cease to continue scib1

Last report 30 in scib, if 85% or more is the norm then 27 is achievable just from those . One was heading to 30% shrinkage, which would make 12 out of 13 if they did (92%)

chilltime
14/6/2024
09:24
Sci102
Member since: 01 Dec 2023

Only posts on Scancell


Enough said?

dominiccummings
14/6/2024
09:16
OK enough is enough. It is nearly time for my exit so I'm gonna let you fools resume the pumping.

Goodbye

sci102
14/6/2024
08:47
at least some trades this morning. Struggling to understand the low volumes here particularly after the Lindy interview.....
connello
14/6/2024
08:37
the registrational trial is no different to the trial we are currently running from a patient perspective, a control arm does not add complexity only costs

but what makes Scancell so interesting is the number of patients

YOU do not need 1000's to prove 85% ORR

because its non toxic ... it makes interim approval very easy



WeTookPelham

Posts: 3,960

Price: 11.00

No Opinion

RE: A pivitol week, a pivtol video...Today 08:00
@mattrempit - fair enough. But my issue is you saying Lindy "wants" Scancell to take this through to the end, (with the inevitable costs and time). I don't think this is realistic, more importantly I don't think Lindy believes this is realistic either (IMO), and she categorically says they would consider offers from big pharma. Hence I felt I had to respond to your comment.

inanaco
14/6/2024
08:28
SC102 concentrating on patient numbers is pointless

has no value

Scancell release data at specific points on the current trials ...

the Null hypothesis THAT DATA IS THEN BANKED ............

the software i have found proves Scancell data is correct

you seem to be obsessed with numbers ... but have no shares !

inanaco
14/6/2024
08:16
Nothing is ever your fault Sci. A narcissist could never accept that.
countbruga
14/6/2024
08:00
The problem those folks have of attacking me is plain and simple

just one post done years ago

which one has failed

Scib1

or

Keytruda

= no risk ...... they have to work together

inanaco
14/6/2024
07:57
tf he is after me ... he told us all his job was probabilities

and he produced a page of A4 drivel ..

nobody averages cancer shrinkage as an endpoint !! or eliminates the failures to make the maths work

so i can see why Ruck would be "embarrassed" his efforts are on par with SC102

inanaco
14/6/2024
07:55
TF, Maybe I should have said narcissists (plural):)
ruckrover
14/6/2024
07:53
Inan,"Buy and Hold"Whilst I disagree with the strategy in general I have bought and I am holding!
ruckrover
14/6/2024
07:52
Well said Ruck, (but in your last para you are very hard on Lozan).
torquayfan
14/6/2024
07:51
Ruckrover except I have your Towel ............. and i can see your 40p retirement !! coming soon

SC102 cannot do that !

inanaco
14/6/2024
07:49
Fact SC102 No Shares and probably no money

as Money talks ... loudest

Redmile
Vulpes
Vulpes sit on the board and both would be aware of Scancells desire to run to approval

no sells

we are looking at a very serious share price if we have an approved product with a 16 year patent with sales of $1.5b

which could double again if we target adjuvant melanoma

Scancell could get approval at the start of phase 3 if the ORR is above 70%

I have shown many trials with this happening .....

If you have followed my posts you will make a fortune

Buy and Hold

inanaco
14/6/2024
07:41
Chilltime thanks for those posts. I see the 'Litter Free' thread has been cancelled, (with the result that Sci102 is here now). But Sci102 is best on filter IMO.
torquayfan
14/6/2024
07:35
"Fact" 😅😅😅😅 8517;😅
sci102
14/6/2024
07:34
Sci102 filtered.
rogerbridge
Chat Pages: Latest  2709  2708  2707  2706  2705  2704  2703  2702  2701  2700  2699  2698  Older

Your Recent History

Delayed Upgrade Clock